C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2006
10/26/2006	US20060239967 Oncolytic virus replicating selectively in tumor cells
10/26/2006	US20060239966 In vivo gene therapy of parkinson's disease
10/26/2006	US20060237025 Method of reducing the harmful effects of orally or transdermally delivered nicotine
10/26/2006	DE112004001708T5 Verfahren zur Herstellung einer nützlichen Zwischenstufe in der Alkaloid-Biosynthese unter Verwendung von RNAi-Technik A process for preparing a useful intermediate in the alkaloid biosynthesis using RNAi technology
10/26/2006	DE10211358B4 Vertikal-Impedanz-Sensor-Anordnung und Verfahren zum Herstellen einer Vertikal-Impedanz-Sensor-Anordnung Vertical-impedance sensor arrangement and method of manufacturing a vertical-impedance sensor arrangement
10/26/2006	DE102005019040A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung verbesserter Stämme der Familie Enterobacteriaceae A process for the preparation of L-amino acids using strains of the Enterobacteriaceae family improved
10/26/2006	CA2792443A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
10/26/2006	CA2608410A1 A novel .beta.-galactoside-.alpha.2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
10/26/2006	CA2606156A1 Mitochondrial mutations and rearrangements as a diagnostic tool for the detection of sun exposure, prostate cancer and other cancers
10/26/2006	CA2605964A1 High affinity fully human monoclonal antibodies to interleukin-8 and epitopes for such antibodies
10/26/2006	CA2605957A1 Highly safe intranasally administrable gene vaccines for treating alzheimer's disease
10/26/2006	CA2605512A1 Modulation of exon recognition in pre-mrna by interfering with the binding of sr proteins and by interfering with secondary rna structure.
10/26/2006	CA2605402A1 Antibody neutralizers of human granulocyte macrophage colony stimulating factor
10/26/2006	CA2605393A1 Expression cassettes for seed-preferential expression in plants
10/26/2006	CA2604925A1 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
10/26/2006	CA2604807A1 Improved methods controlling gene expression
10/26/2006	CA2604732A1 Vaccine against pandemic strains of influenza viruses
10/26/2006	CA2604705A1 Porcine circovirus and helicobacter combination vaccines
10/26/2006	CA2604580A1 Methods for modulating bone formation and mineralization by modulating krc activity
10/26/2006	CA2604515A1 Toll-like receptor 14 (tlr14 ) and use thereof
10/26/2006	CA2604222A1 Il-21 variants
10/26/2006	CA2602635A1 Method of altering the binding specificity of proteins by oxidation-reduction reactions
10/26/2006	CA2600986A1 Mammalian expression vector comprising the mcmv promoter and first intron of hcmv major immediate early gene
10/26/2006	CA2574572A1 Modulation of cytokine signaling regulators and applications for immunotherapy
10/26/2006	CA2503468A1 Detection and identification of enteroviruses
10/25/2006	EP1715340A2 Method and apparatus for making an array for rapid molecular profiling
10/25/2006	EP1715064A1 Nucleotide sequences derived from the genomes of the retroviruses HIV-1, HIV-2 and SIV, and their application to the amplification of these viral genomes and to the in vitro diagnosis of infections resulting from these viruses
10/25/2006	EP1715063A2 Hybridisation beacon and method of rapid sequence detection and discrimination
10/25/2006	EP1715062A2 Method for detecting human papillomavirus mRNA
10/25/2006	EP1715058A2 Multiplex amplification of short tandem repeat loci
10/25/2006	EP1715054A1 Processes for producing optically active 1-substituted 2-methylpyrrolidine and intermediate therefor
10/25/2006	EP1715053A1 Gene trap cassettes for random and targeted conditional gene inactivation
10/25/2006	EP1715052A1 Composition and method for elevating gene transfer efficiency
10/25/2006	EP1715051A1 Gene construct systems for isolating a pure population of cells of a single cell type
10/25/2006	EP1715050A1 Paraquat resistance gene and a vascular tissue- and trichome-specific promoter
10/25/2006	EP1715049A1 Method of detecting and quantifying human P450 molecular species and probe and kit for this method
10/25/2006	EP1715048A1 Process for producing virus vector
10/25/2006	EP1715047A2 Recombinant mutants for inducing specific immune responses
10/25/2006	EP1715046A2 New polypeptide, DNA encoding the polypeptide, recombinant vector bearing the DNA and recombinant virus utilizing the recombinant vector as well as use thereof
10/25/2006	EP1715045A2 Recombinant antibodies for human therapy
10/25/2006	EP1715044A2 Human neurexin-like proteins and polynucleotides encoding the same
10/25/2006	EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/25/2006	EP1715041A1 Method of detecting cancer cell acquiring drug-resistance
10/25/2006	EP1715040A2 Zinc finger binding domains for GNN
10/25/2006	EP1715039A1 Method of isolating a nucleic acid using a bifunctional material containing an amino group and a carboxyl group
10/25/2006	EP1715038A1 Antibody targeting osteoclast-associated protein
10/25/2006	EP1715037A1 Method of amplifying nucleic acid
10/25/2006	EP1715035A2 Synthetic polynucleotides encoding lysyl oxidase
10/25/2006	EP1714980A1 Human receptor proteins, related reagents and methods
10/25/2006	EP1714979A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/25/2006	EP1714975A2 Gene and peptide for transcriptional repressor
10/25/2006	EP1714974A2 HIV-1-and HIV-2-peptides for inhibition of membranes fusion-associated events, including HIV transmission
10/25/2006	EP1714972A2 Method for producing a peptide with a pl above 8 or below 5
10/25/2006	EP1714971A2 Directed switch-mediated DNA recombination
10/25/2006	EP1714970A1 Use of inhibitors of RNAse A-family enzymes for stabilizing oligonucleotides having RNA interfering activity
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1714543A2 Plants having mutant sequences that confer altered fatty acid profiles
10/25/2006	EP1714155A1 Non-invasive real-time in vivo bioluminescence imaging of local ca2+ dynamics in living organisms
10/25/2006	EP1713930A1 Rapid screening method of translational fusion partners for producing recombinant proteins and translational fusion partners screened therefrom
10/25/2006	EP1713923A1 Enzymatic asymmetric decarboxylation of disubstituted malonic acids
10/25/2006	EP1713921A2 Expression of plasminogen and microplasminogen in duckweed
10/25/2006	EP1713920A1 A method for regulating plant growth
10/25/2006	EP1713919A2 Protease variants
10/25/2006	EP1713918A1 Oligonucleotide for genotyping of mycoplasma, microarray comprising the oligonucleotide, and method for detection of species using the microarray
10/25/2006	EP1713917A2 Pneumolysin derivatives
10/25/2006	EP1713916A1 Novel mirna molecules isolated from human embryonic stem cell
10/25/2006	EP1713915A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (MULTIFUNCTIONAL siNA)
10/25/2006	EP1713914A2 MEDICAL TREATMENT USING AN RNAi AGENT TARGETING A HUMAN NOTCH SIGNALLING PATHWAY MEMBER
10/25/2006	EP1713913A2 Screening assays
10/25/2006	EP1713912A1 Modified short interfering rna (modified sirna)
10/25/2006	EP1713911A1 Probe set and method for identifying hla allele
10/25/2006	EP1713910A1 Method for chromatographic separation of a nucleic acid mixture
10/25/2006	EP1713909A2 Altering root structure during plant development
10/25/2006	EP1713908A2 Recombinant dna for gene suppression
10/25/2006	EP1713907A2 Hybrid proteins of active-site serine beta-lactamase.
10/25/2006	EP1713905A1 Protein with activity of hydrolyzing amylopectin, starch, glycogen and amylose, gene encoding the same, cell expressing the same, and production method thereof
10/25/2006	EP1713828A2 Enhanced secretion/retention of growth hormone releasing hormone (ghrh) from muscle cells by species-specific signal peptide
10/25/2006	EP1713825A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
10/25/2006	EP1713824A2 Recombinant viruses with heterologous envelope proteins
10/25/2006	EP1713819A2 Methods and compositions for combination rnai therapeutics
10/25/2006	EP1713511A1 Therapeutic agent for treatment of cancer comprising human apolipoprotein (a) kringles lk68 or lk8 genes as effective ingredient, and method for treating cancer using the same
10/25/2006	EP1713507A2 Adept or gdept production of acetaldehyde
10/25/2006	EP1713440A2 Engineered proteins, and methods of making and using
10/25/2006	EP1713337A2 Modulation of line-1 reverse transcriptase
10/25/2006	EP1670948A4 GENE MODULATION BY RB2/p130 EXPRESSION
10/25/2006	EP1578967A4 Fluorescent proteins from aquatic species
10/25/2006	EP1543018A4 Gene families associated with liver cancer
10/25/2006	EP1423417B1 Antibodies recognizing a peptide mimicking a cryptic epitope of gp41 of hiv-1
10/25/2006	EP1409525B1 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
10/25/2006	EP1332155B1 Immunization of dairy cattle with gapc protein against streptococcus infection
10/25/2006	EP1292615B1 Modified morbillivirus v proteins
10/25/2006	EP1194537B1 Mutated nurr1 gene
10/25/2006	EP1153302B1 Diagnostics and therapeutics for macular degeneration
10/25/2006	EP1148947B1 Fibre array for contacting chemical species and methods for using and making same
10/25/2006	EP1129112B1 Peptides containing a cholesterol recognition sequence and their uses
10/25/2006	EP1109901B1 GABA B RECEPTOR SUBTYPES GABA B-R1c AND GABA B-R2 AND HETERODIMERS THEREOF
10/25/2006	EP1107993B1 Human monoclonal antibodies directed against the islet cell antigen ia-2
10/25/2006	EP1104488B1 Linking gene sequence to gene function by three dimensional (3d) protein structure determination
10/25/2006	EP1097167B1 Neurotrophic growth factor
10/25/2006	EP1095054B1 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation

1 ... 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 ... 4023